For the first time, fetal medicine experts have performed prenatal heart surgery to remove a life-threatening tumor, called intrapericardial teratoma.
Federal agencies concerned with infant health and welfare have announced their support of the American Academy of Pediatrics (AAP) updated recommendations on safe infant sleep.
AbbVie (NYSE: ABBV), a global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), have announced detailed results from two replicate pivotal Phase 3 clinical trials evaluating the efficacy and safety of Elagolix in premenopausal women who suffer from endometriosis.
Having completed over 800 aligner cases with AcceleDent®, Dr. Kenji Ojima, one of the world’s most prominent orthodontists, reports a standard five-day wear time for nearly all of his aligner patients using AcceleDent.
A new report on Swedish men with non-aggressive prostate cancer suggests that a lot more American men could safely choose to monitor their disease instead of seeking immediate radiation treatment or surgery.
A new study conducted by the Colorado Center for Reproductive Medicine (CCRM) concludes that assisted reproductive technology (ART) results in live birth gender rates skewed towards male babies.
Researchers studying reproductive science identified a network of proteins often linked to cancer as also important to male fertility and the birth of healthy offspring, according to a study in the Oct. 18 online issue of Cell Reports.
Scientists at UEG Week have announced that faecal bacterial profiles differ in irritable bowel syndrome (IBS) patients who respond favourably to a low-FODMAP diet and those who do not. This will allow doctors to predict which patients will benefit from following the diet, rather than asking patients to trial the challenging diet plan.
On Saturday, October 22, over three thousand participants are expected to gather at Lansdowne Park to take part in The Leukemia & Lymphoma Society of Canada’s 7th annual Light The Night Walk in Ottawa.